Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.28
-0.0200-1.54%
Post-market: 1.280.00000.00%17:50 EDT
Volume:735.89K
Turnover:936.58K
Market Cap:77.17M
PE:-1.46
High:1.30
Open:1.30
Low:1.25
Close:1.30
Loading ...

Top Executives at IGM Biosciences Make Significant Stock Sales!

TIPRANKS
·
26 Jul

IGM Biosciences' Chief Business Officer Lisa Lynn Decker Reports Disposal of Common Shares

Reuters
·
26 Jul

Pulse Biosciences Inc. Appoints Steven T. Weber as Vice President of Accounting and Principal Accounting Officer

Reuters
·
15 Jul

Wedbush Cuts Price Target on IGM Biosciences to $1.25 From $3, Keeps Neutral Rating

MT Newswires Live
·
02 Jul

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires Live
·
02 Jul

IGM Biosciences moved to No Rating at BofA

TIPRANKS
·
02 Jul

IGM Biosciences to Be Acquired by Concentra Biosciences for $1.247 Per Share Plus Contingent Value Rights

Reuters
·
01 Jul

IGM Biosciences Inc. Chief Business Officer Lisa Lynn Decker Reports Disposal of Common Shares

Reuters
·
21 Jun

IGM Biosciences Faces Nasdaq Non-Compliance Notice

TIPRANKS
·
12 Jun

IGM Biosciences Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement

Reuters
·
12 Jun

IGM Biosciences Is Maintained at Hold by Truist Securities

Dow Jones
·
12 Jun

Analysts Offer Insights on Healthcare Companies: Merus (MRUS) and IGM Biosciences (IGMS)

TIPRANKS
·
11 Jun

Truist Cuts Price Target on IGM Biosciences to $1 From $2, Keeps Hold Rating

MT Newswires Live
·
11 Jun

IGM Biosciences Reports Increased Net Loss Amid Strategic Focus

TIPRANKS
·
03 Jun

IGM Biosciences Inc. Principal Accounting Officer Steven Weber Reports Disposal of Common Shares

Reuters
·
17 May

IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

IGM Biosciences Q1 EPS $(0.50) Misses $(0.48) Estimate, Sales $499.00K Miss $3.10M Estimate

Benzinga
·
14 May

BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination Genzyme Corp That Certain Collaboration And License Agreement

Reuters
·
09 May

IGM Biosciences Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
02 May

IGM Biosciences downgraded to Underperform from Neutral at BofA

TIPRANKS
·
08 Apr